SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-219243
Filing Date
2022-08-12
Accepted
2022-08-12 06:54:06
Documents
105
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d386349d6k.htm   iXBRL 6-K 194120
2 EX-99.1 d386349dex991.htm EX-99.1 129012
3 EX-99.2 d386349dex992.htm   iXBRL EX-99.2 1304544
9 GRAPHIC g386349g97u07.jpg GRAPHIC 6967
  Complete submission text file 0001193125-22-219243.txt   8806828

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA asln-20220630.xsd EX-101.SCH 92534
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asln-20220630_cal.xml EX-101.CAL 57825
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asln-20220630_def.xml EX-101.DEF 327277
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE asln-20220630_lab.xml EX-101.LAB 521588
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asln-20220630_pre.xml EX-101.PRE 467609
99 EXTRACTED XBRL INSTANCE DOCUMENT d386349d6k_htm.xml XML 1894347
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38475 | Film No.: 221157763
SIC: 2834 Pharmaceutical Preparations